🔍

MKPL - M K Proteins

📊 NSE: MKPL 🏢 Solvent Extraction 📅 Last Updated: 12/14/2025 9:22

📢 Recent Corporate Announcements

MKPL Q3 FY26 Revenue Jumps 127% YoY to ₹89.56 Cr; Net Profit Rises to ₹1.43 Cr

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 13 Feb 2026, 04:21 PM

M K Proteins Limited reported a substantial 127% YoY increase in revenue for Q3 FY26, reaching ₹89.56 crore compared to ₹39.48 crore in the previous year. However, net profit grew by only 4% YoY to ₹1.43 crore, indicating significant margin pressure as expenses rose sharply. For the nine-month period ending December 2025, revenue surged 81.5% to ₹236.93 crore, while net profit saw a marginal increase to ₹5.69 crore. The sharp rise in raw material costs and stock-in-trade purchases impacted the overall profitability despite the robust top-line performance.

Revenue from operations grew 126.8% YoY to ₹89.56 crore in Q3 FY26.
Net profit for the quarter increased slightly by 4% YoY to ₹1.43 crore.
9-month revenue reached ₹236.93 crore, up from ₹130.50 crore in the previous year.
Quarterly EPS improved to ₹0.04 compared to ₹0.02 in the previous quarter.
Total expenditure for the quarter rose to ₹87.61 crore, driven by a surge in material consumption and stock purchases.

💡 While the top-line growth is exceptional, the stagnant bottom line suggests rising input costs are significantly impacting margins. Investors should monitor the company's ability to pass on costs to maintain profitability before making aggressive entries.

M K Proteins Q3 FY26 Revenue Surges 126% YoY to Rs 89.55 Crore

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 13 Feb 2026, 04:14 PM

M K Proteins Limited (MKPL) reported a massive 126% year-on-year increase in revenue from operations for Q3 FY26, reaching Rs 8,955.83 lacs. However, net profit saw a more modest growth of 4%, rising to Rs 143.08 lacs from Rs 137.52 lacs in the previous year's corresponding quarter. For the nine-month period ended December 2025, the company achieved a revenue of Rs 23,693.46 lacs, nearly doubling its performance compared to the same period last year. The results indicate strong top-line momentum but suggest significant pressure on operating margins due to increased material costs.

Revenue from operations grew 126.8% YoY to Rs 8,955.83 lacs in Q3 FY26.
Net profit for the quarter stood at Rs 143.08 lacs, up from Rs 137.52 lacs in Q3 FY25.
Nine-month revenue for FY26 reached Rs 23,693.46 lacs compared to Rs 13,050.19 lacs in 9M FY25.
Cost of materials consumed rose sharply to Rs 8,569.66 lacs in Q3 FY26 from Rs 2,003.69 lacs in Q3 FY25.
Earnings Per Share (EPS) for the quarter remained stable at Rs 0.04.

💡 Investors should note the exceptional top-line growth but remain cautious about the thinning profit margins as raw material costs have scaled significantly. Monitor if the company can improve its operational efficiency to translate high sales into higher bottom-line growth in future quarters.

M K Proteins Reports 100% Demat Shareholding for Quarter Ended December 2025

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 14 Jan 2026, 11:19 AM

M K Proteins Limited has submitted its compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the quarter ended December 31, 2025. The company's Registrar and Share Transfer Agent (RTA), Bigshare Services Private Limited, confirmed that no requests for dematerialization or rematerialization were received during this period. Notably, the RTA stated that the entire holding of the company's shares is already in demat form. This is a standard quarterly regulatory filing ensuring the integrity of shareholding records.

Confirmed compliance with SEBI (Depositories and Participants) Regulations for Q3 FY2025-26.
100% of the company's shares are currently held in dematerialized form.
Zero requests for dematerialization or rematerialization were processed during the quarter ended December 31, 2025.
Bigshare Services Private Limited served as the Registrar and Share Transfer Agent (RTA).

💡 This is a routine administrative filing with no impact on company fundamentals; investors should continue to monitor financial performance and growth metrics.

M K Proteins Limited Announces Trading Window Closure from January 1, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 29 Dec 2025, 10:05 AM

M K Proteins Limited (MKPL) has notified the exchanges regarding the closure of its trading window starting January 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations for the upcoming Un-Audited Financial Results for the quarter ending December 31, 2025. The window will remain closed for all designated persons, including directors and promoters, until 48 hours after the results are declared. The specific date for the board meeting to approve these results will be communicated in due course.

Trading window closure begins on Thursday, January 1, 2026.
Closure is related to the financial results for the quarter ended December 31, 2025.
The restriction applies to all Employees, Directors, KMPs, and Promoters.
The window will reopen 48 hours after the official declaration of the financial results.
Board meeting date for result approval is yet to be announced.

💡 This is a routine regulatory filing with no direct impact on company fundamentals. Investors should wait for the announcement of the board meeting date to evaluate the upcoming quarterly performance.

View All MKPL Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Group revenue is expected to grow by 4-5% in fiscal 2025 and 5% in the medium term. Standalone revenue for MKPL grew 9.01% to INR 267.71 Cr in FY25 from INR 245.57 Cr in FY24. The MKP partnership firm reported TOI of Rs 93.60 Cr in FY24 and expects ~Rs 150 Cr in FY25.

Geographic Revenue Split

Not disclosed in available documents, though operations are primarily concentrated in Gujarat, which is a major producer of groundnuts.

Profitability Margins

Standalone Net Profit Margin declined to 3.14% in FY25 from 4.57% in FY24 due to lower volumes and prices. Group operating margins are expected to remain steady at 6-6.5% over the medium term, aided by backward integration.

EBITDA Margin

Group operating margins are projected at ~6.5% for fiscal 2025. The MKP partnership firm reported an operating profit margin of 3.46% (Rs 3.24 Cr) in FY24.

Capital Expenditure

The group plans modest debt-funded capital expenditure of Rs 10-12 Cr in the medium term. Standalone fixed asset purchases were INR 0.096 Cr in FY25.

Credit Rating & Borrowing

Crisil Ratings: Stable (Group); CARE Ratings: CARE BB-; Stable / CARE A4 (MKP firm). Interest coverage is expected to improve to 13 times in fiscal 2025 from 10 times in fiscal 2024.

⚙️ Operational Drivers

Raw Materials

Groundnut seeds, rice bran, and sunflower seeds are the primary raw materials used for oil extraction and refining.

Import Sources

Groundnuts are sourced locally from Gujarat (Morbi/Saurashtra). Palm oil imports are influenced by export taxes from Indonesia and Malaysia.

Key Suppliers

Not disclosed in available documents; procurement is done from farmers and wholesalers in the surrounding locality of the manufacturing units.

Capacity Expansion

The MKP unit has an installed capacity of 50 MTPD for groundnut seeds and 20 MTPD for groundnut oil manufacturing. The group periodically expands production capacity to cater to changing customer needs.

Raw Material Costs

Not disclosed as a specific percentage of revenue, but profit margins are highly susceptible to fluctuations in agro-based raw material prices and government MSP changes.

Manufacturing Efficiency

The refinery is completely mechanized to ensure benchmark product quality (fiber-free, ash-free). Group bank limit utilization is moderate at 40-60%.

Logistics & Distribution

Not disclosed as a specific percentage, but locational advantage in Gujarat significantly reduces logistics and storage expenditure.

📈 Strategic Growth

Expected Growth Rate

Growth Strategy

Growth will be achieved through established relationships with key customers, improving geographical diversity, and sustained levels of cleaning, storage, and monitoring in mechanized refineries to meet customer specifications.

Products & Services

Groundnut refined oil, rice bran oil, sunflower oil, groundnut oil cake, and groundnut seeds.

Market Expansion

The group is focused on improving geographical diversity and increasing production capacity to cater to varied customer needs.

Market Share & Ranking

Not disclosed in available documents; the industry is noted as highly fragmented with numerous players.

🌍 External Factors

Industry Trends

The edible oil industry is highly fragmented and competitive, with a shift toward mechanized refining and benchmark product quality to meet customer requirements.

Competitive Landscape

Intense competition from numerous fragmented players and aggressive pricing by competing brands create potential for disruption.

Competitive Moat

Locational advantage in Gujarat (the largest groundnut producer) provides a sustainable cost moat by reducing logistics and procurement costs.

Macro Economic Sensitivity

Highly sensitive to monsoon patterns affecting oilseed procurement and changes in the Minimum Support Price (MSP) offered by the government.

Consumer Behavior

Customers exhibit high price sensitivity, switching to cheaper international imports when domestic realizations are high.

Geopolitical Risks

Profitability is sensitive to changes in export taxes levied by major exporting countries like Indonesia and Malaysia on palm oil.

⚖️ Regulatory & Governance

Industry Regulations

Operations are affected by import-export regulations, minimum support price (MSP) on oilseeds, and mechanized refinery standards.

Legal Contingencies

The company faces contingent liabilities relating to taxation, litigations, and claims arising in the normal course of business; specific INR values are not disclosed.